Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Katharine Murkett"'
Publikováno v:
Neuropsychiatric Disease and Treatment
A PubMed review was conducted for papers reporting on attention-deficit/hyperactivity disorder (ADHD) in postsecondary students. The review was performed in order to determine the prevalence and symptomatology of ADHD in postsecondary students, to ex
Autor:
Katharine Murkett, Vanja Sikirica, Amaia Hervás, Jeffrey Newcorn, Valerie Harpin, Brigitte Robertson, Michael Huss
Publikováno v:
Neuropsychiatric Disease And Treatment
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
Neuropsychiatric Disease and Treatment, Vol 2016, Iss Issue 1, Pp 1085-1101 (2016)
Neuropsychiatric Disease and Treatment
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
Neuropsychiatric Disease and Treatment, Vol 2016, Iss Issue 1, Pp 1085-1101 (2016)
Neuropsychiatric Disease and Treatment
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
Guanfacine extended release (GXR) and atomoxetine (ATX) are nonstimulant treatments for attention-deficit/hyperactivity disorder (ADHD). As nonstimulant treatments are often used after stimulants in ADHD, GXR was assessed relative to prior stimulant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c06683f051d7c3c68b69a86628700339
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=13400
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=13400
Publikováno v:
Neuropsychiatric Disease and Treatment
Johannah Sharman, Michael Pennick Shire, Basingstoke, UK Abstract: Lisdexamfetamine dimesylate (LDX) is approved as a once-daily treatment for attention-deficit/hyperactivity disorder in children, adolescents, and adults in some countries. LDX is a p
Autor:
Katharine Murkett, Tobias Banaschewski, Michel Lecendreux, Cesar Soutullo, Alessandro Alessandro Zuddas, Ben Adeyi, Shaw Sorooshian, David Coghill
Publikováno v:
Neuropsychiatric Disease and Treatment
David R Coghill,1 Tobias Banaschewski,2 Michel Lecendreux,3 César Soutullo,4 Alessandro Zuddas,5 Ben Adeyi,6 Shaw Sorooshian7 1Division of Neuroscience, University of Dundee, Dundee, UK; 2Child and Adolescent Psychiatry and Psychotherapy, Central In